Position in HROW
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$464,832
-$238,269 QoQ
Shares Held
13,183
-8.1% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
6 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in HROW Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Bleakley Financial Group, LLC holds $14,751,437 across 10 Drug Manufacturers - Specialty & Generic names. HROW ranks #7 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TAK |
Takeda Pharmaceutical Co Ltd
|
431,602 | $7,993,269 | |
| 2 | ZTS |
Zoetis Inc.
|
18,748 | $2,216,201 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
13,951 | $1,058,183 | |
| 4 | LQDA |
Liquidia Corp
|
22,855 | $862,547 | |
| 5 | PBH |
Prestige Consumer Healthcare Inc.
|
12,245 | $725,761 | |
| 6 | AQST |
Aquestive Therapeutics, Inc.
|
135,767 | $563,433 | |
| 7 | HROW |
Harrow, Inc.
This page
|
13,183 | $464,832 | |
| 8 | ALKS |
Alkermes plc.
|
10,064 | $355,863 |
All Filings in HROW
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $464,832 | 13,183 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $703,101 | 14,349 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $681,602 | 14,147 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $439,073 | 14,377 | Shares | Sole | 2025-07-30 | |
| 2024-12-31 | $294,233 | 8,770 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $241,704 | 5,376 | Shares | Sole | 2024-10-16 | |
| No filing history on record for this holder in this stock. | ||||||